Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis

PHASE4RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 24, 2022

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions
De Quervain Tenosynovitis
Interventions
PROCEDURE

Intra-sheath injection

Ultrasound guided corticosteroid injection composed of 1ml of 1% lidocaine and 1ml (20mg) of dexamethasone. Injection will be administered directly into the abductor pollicis longus/ extensor pollicis brevis sheath.

PROCEDURE

Extra-sheath injection

Ultrasound guided corticosteroid injection composed of 1ml of 1% lidocaine and 1ml (20mg) of dexamethasone. Injection will be administered surrounding the abductor pollicis longus/ extensor pollicis brevis sheath.

DEVICE

Ultrasound

To ensure accuracy of fluid deposition into the tendon sheath in the intra-sheath injection arm and outside of the tendon sheath in the extra-sheath injection arm, all injections will be performed under ultrasound guidance. The ultrasound machine used will be a portable ultrasound machine located at the UC Davis orthopaedic clinic in Sacramento

Trial Locations (1)

95817

RECRUITING

UC Davis Health, Department of Orthopaedics, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT04895956 - Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis | Biotech Hunter | Biotech Hunter